| PCa | Prostate cancer |
| ADT | Androgen deprivation therapy |
| AR | Androgen receptor |
| CRPC | Castration-resistant PCa |
| DBD | DNA-binding domain |
| LBD | Ligand-binding domain |
| ARE | Androgen-responsive elements |
| AR-Vs | AR splice variants |
| DHT | Dihydrotestosterone |
| BF3 | Binding function 3 |
| AF-1 | Activation function-1 |
| UTR | Untranslated region |
| lncRNA | Long non-coding RNA |
| Topo II | Topoisomerase II |
| ER | Endoplasmic reticulum |
| HDAC1 or HDAC3 | Histone deacetylase 1 or 3 |
| CDK1 or 9 | Cyclin-dependent kinase 1 or 9 |
| GATA2 | GATA-binding protein 2 |
| PCGEM1 | Prostate cancer gene expression marker 1 |
| BET | Bromodomain and extra terminal |
| RASD1 | Ras dexamethasone-induced 1 |
| TIPARP | TCDD-inducible poly (ADP-ribose) polymerase |
| SGK1 | Serum- and glucocorticoid-regulated kinase 1 |